| title |
Late-stage results from the probe development effort to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2): absorbance-based cell-based dose response inhibition assay |